FINANCIAL MODEL AND BUSINESS PLAN (GENAVIA THERAPEUTICS)
Genavia was a start-up bio-tech venture whose business plan featured considerable market and technical risk along with an opportunity for spectacular returns. Scarlatti developed a financial model that dealt with this uncertainty and assigned probabilities and value projections to the extensive range of potential outcomes. This allowed Genavia to communicate appropriately the potential risks and returns from its business plan to investors.